Galleria mellonella infection model demonstrates high lethality of ST69 and ST127 uropathogenic E. coli

PLoS One. 2014 Jul 25;9(7):e101547. doi: 10.1371/journal.pone.0101547. eCollection 2014.

Abstract

Galleria mellonella larvae are an alternative in vivo model for investigating bacterial pathogenicity. Here, we examined the pathogenicity of 71 isolates from five leading uropathogenic E. coli (UPEC) lineages using G. mellonella larvae. Larvae were challenged with a range of inoculum doses to determine the 50% lethal dose (LD50) and for analysis of survival outcome using Kaplan-Meier plots. Virulence was correlated with carriage of a panel of 29 virulence factors (VF). Larvae inoculated with ST69 and ST127 isolates (10(4) colony-forming units/larvae) showed significantly higher mortality rates than those infected with ST73, ST95 and ST131 isolates, killing 50% of the larvae within 24 hours. Interestingly, ST131 isolates were the least virulent. We observed that ST127 isolates are significantly associated with a higher VF-score than isolates of all other STs tested (P≤0.0001), including ST69 (P<0.02), but one ST127 isolate (strain EC18) was avirulent. Comparative genomic analyses with virulent ST127 strains revealed an IS1 mediated deletion in the O-antigen cluster in strain EC18, which is likely to explain the lack of virulence in the larvae infection model. Virulence in the larvae was not correlated with serotype or phylogenetic group. This study illustrates that G. mellonella are an excellent tool for investigation of the virulence of UPEC strains. The findings also support our suggestion that the incidence of ST127 strains should be monitored, as these isolates have not yet been widely reported, but they clearly have a pathogenic potential greater than that of more widely recognised clones, including ST73, ST95 or ST131.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Communicable Diseases / microbiology*
  • Communicable Diseases / pathology
  • Humans
  • Larva / genetics
  • Larva / microbiology*
  • Lepidoptera / genetics
  • Lepidoptera / microbiology*
  • O Antigens / genetics
  • Serogroup
  • Uropathogenic Escherichia coli / classification
  • Uropathogenic Escherichia coli / pathogenicity*
  • Virulence / genetics

Substances

  • O Antigens

Grants and funding

The first author (MA) was supported by a grant from King Abdullah International Medical Research Center, Saudi Arabia -Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.